Functional Link between miR-200a and ELK3 Regulates the Metastatic Nature of Breast Cancer

Triple-negative breast cancer (TNBC) refers to breast cancer that does not have receptors for estrogen, progesterone, and HER2 protein. TNBC accounts for 10-20% of all cases of breast cancers and is characterized by its metastatic aggressiveness, poor prognosis, and limited treatment options. Here,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers 2020-05, Vol.12 (5), p.1225
Hauptverfasser: Kim, Hyung-Keun, Park, Joo Dong, Choi, Seung Hee, Shin, Dong Jun, Hwang, Sohyun, Jung, Hae-Yun, Park, Kyung-Soon
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Triple-negative breast cancer (TNBC) refers to breast cancer that does not have receptors for estrogen, progesterone, and HER2 protein. TNBC accounts for 10-20% of all cases of breast cancers and is characterized by its metastatic aggressiveness, poor prognosis, and limited treatment options. Here, we show that the metastatic nature of TNBC is critically regulated by a functional link between miR-200a and the transcription factor ELK3. We found that the expression levels of miR-200a and the mRNA were negatively correlated in the luminal and TNBC subtypes of breast cancer cells. experiments revealed that miR-200a directly targets the 3' untranslated region (UTR) of the mRNA to destabilize the transcripts. Furthermore, ectopic expression of miR-200a impaired the migration and invasion of TNBC cells by reducing the expression level of the mRNA. In studies, transfection of MDA-MB 231 cells (a claudin-low TNBC cell type) with exogenous miR-200a reduced their extravasation into the lung during 48 h after tail vein injection, and co-transfection of the cells with an expression plasmid harboring ELK3 that lacked an intact 3'UTR recovered their extravasation ability. Overall, our findings provide evidences that miR-200a and is functionally linked to regulate invasive characteristics of breast cancers.
ISSN:2072-6694
2072-6694
DOI:10.3390/cancers12051225